Updated Jul 16, 2026
Kiely John has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $438K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-08 | AMRX | Amneal Pharmaceuticals, Inc. | M — Option exercise | 34.8K | — | |
| 2025-08-27 | AMRX | Amneal Pharmaceuticals, Inc. | S — Open-market sale | 32.0K | $9.23 | $295K |
| 2024-11-26 | AMRX | Amneal Pharmaceuticals, Inc. | S — Open-market sale | 17.1K | $8.38 | $143K |
| 2024-11-26 | AMRX | Amneal Pharmaceuticals, Inc. | M — Option exercise | 28.5K | $4.76 | $136K |
Kiely John is a corporate insider — currently tracked as Director of Amneal Pharmaceuticals, Inc. (AMRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($438K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kiely John profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.